by Jordana Choucair | Jan 12, 2022 | Life Sciences
The federal government ordered another 600,000 doses of GlaxoSmithKline PLC and Vir Biotechnology Inc.’s monoclonal antibody treatment for COVID-19. The drugmakers plan to deliver the treatment, which is the only one thought to work against the Omicron variant,...
by Jordana Choucair | Jan 12, 2022 | Opioid/Substance Use Disorders
A new study published in JAMA Network Open found that the annual opioid overdose death rate per 100,000 persons for adults aged 55 and older increased substantially since 2019. Furthermore, rates varied substantially by sex and by race and ethnicity over time....
by Jordana Choucair | Jan 12, 2022 | Public Health/Prevention
Federal officials acknowledged Tuesday that most people will be infected with COVID-19 regardless of vaccination status. Anthony Fauci said that Omicron will infect “just about everybody,” but that those who have been vaccinated will “very likely, with some...
by Jordana Choucair | Jan 11, 2022 | Public Health/Prevention
The CDC is weighing an update to its mask guidance to recommend that people wear N95 or KN95 masks, the highly protective masks worn by medical workers, if they can do so consistently. The Biden administration has so far declined to officially recommend that people...
by Jordana Choucair | Jan 11, 2022 | Public Health/Prevention
The United States reported 1.35 million new COVID-19 infections on Monday, the highest daily total for any country in the world. The seven-day average for new cases has tripled in two weeks to over 700,000 new infections a day. According to data from HHS, 141,385...
by Jordana Choucair | Jan 11, 2022 | Providers
Almost a quarter of U.S. hospitals are reporting “critical staffing shortages” as counties across the country set COVID-19 case records. According to HHS data, approximately 24 percent of nearly 5,000 hospitals are experiencing the shortages — the most...
Recent Comments